Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients

European Journal of Radiology

Volumn 83, Issue 9, 2014, Pages 1665-1671

  Ippolito, Davide ^a,b   Fior, Davide ^a,b   Bonaffini, Pietro Andrea ^a,b   Capraro, Cristina ^a,b   Leni, Davide ^b   Corso, Rocco ^b   Sironi, Sandro ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b Department of Diagnostic Radiology H S Gerardo Monza ^*  (Italy)

Author keywords

Computed tomography; Hepatocellular carcinoma; Perfusion CT; Radiofrequency ablation; Transarterial chemoembolization; Treatment response

Indexed keywords

CEFTRIAXONE; DOXORUBICIN; GELATIN SPONGE; IOBITRIDOL; IODINATED POPPYSEED OIL; LIDOCAINE; SPONGOSTAN; UNCLASSIFIED DRUG; XENETIX 350; CONTRAST MEDIUM;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTERIOGRAPHY; ARTERY CATHETER; ARTERY PERFUSION; ARTICLE; BLOOD VOLUME; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER SIZE; CHEMOEMBOLIZATION; CHILD PUGH SCORE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FLOW RATE; FUNCTIONAL STATUS; HEPATIC ARTERY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; LIVER PARENCHYMA; LIVER PERFUSION; MALE; MESENTERIC ARTERY; MICROCATHETER; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIMODALITY CANCER THERAPY; PERFUSION WEIGHTED IMAGING; PORTAL PHLEBOGRAPHY; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RADIOFREQUENCY ABLATION; RADIOFREQUENCY ABLATION DEVICE; RADIOFREQUENCY HEATING SYSTEM; RADIOFREQUENCY LESION GENERATOR; TREATMENT RESPONSE; TUMOR ABLATION; VASCULAR GUIDE WIRE; VERY ELDERLY; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC USE; IMAGE PROCESSING; IMAGE QUALITY; LIVER; LIVER NEOPLASMS; PROCEDURES; RADIOGRAPHY; REPRODUCIBILITY; SURGERY; TREATMENT OUTCOME; VASCULARIZATION;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEOPLASM, RESIDUAL; PROSPECTIVE STUDIES; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 84906312605     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2014.05.040     Document Type: Article

References (26)

1. D.E. Ramsey, L.Y. Kernagis, M.C. Soulen, and J.H. Geschwind Chemoembolization of hepatocellular carcinoma J Vasc Interv Radiol 13 2002 S211 S221
2. J.D. Yang, and L.R. Roberts Epidemiology and management of hepatocellular carcinoma Infect Dis Clin North Am 24 4 2010 899 919
3. S. Shiina, R. Tateishi, T. Arano, K. Uchino, K. Enooku, and H. Nakagawa et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors Am J Gastroenterol 107 4 2012 569 577
4. B.M. Künzli, P. Abitabile, and C.A. Maurer Radiofrequency ablation of liver tumors: actual limitations and potential solutions in the future World J Hepatol 3 1 2011 8 14
5. C. Cammà, F. Schepis, A. Orlando, M. Albanese, L. Shahied, and F. Trevisani et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 2002 47 54
6. H. Kinugasa, K. Nouso, Y. Takeuchi, T. Yasunaka, H. Onishi, and S. Nakamura et al. Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma J Gastroenterol 47 4 2012 421 426
7. H.K. Lim, D. Choi, W.J. Lee, S.H. Kim, S.J. Lee, and H.J. Jang et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT Radiology 221 2001 447 454
8. A.H. Davarpanah, and J.C. Weinreb The role of imaging in hepatocellular carcinoma: the present and future J Clin Gastroenterol 47 Suppl 2013 S7 S10
9. V. Goh, and A.R. Padhani Imaging tumor angiogenesis: functional assessment using MDCT or MRI? Abdom Imaging 31 2 2006 194 199
10. M. Bellomi, G. Petralia, A. Sonzogni, M.G. Zamponi, and A. Rocca CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience Radiology 244 2 2007 486 493
11. C.H. Thng, T.S. Koh, D.J. Collins, and D.M. Koh Perfusion magnetic resonance imaging of the liver World J Gastroenterol 16 13 2010 1598 1609
12. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 3 2011 1020 1022
13. Y.S. Guan, L. Sun, X.P. Zhou, X. Li, and X.H. Zheng Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up World J Gastroenterol 10 2004 3543 3548
14. H.S. Lim, Y.Y. Jeong, H.K. Kang, J.K. Kim, and J.G. Park Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation Am J Roentgenol 187 2006 W341 W349
15. K. Takayasu, S. Arii, N. Matsuo, M. Yoshikawa, M. Ryu, and K. Takasaki et al. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma Am J Roentgenol 175 2000 699 704
16. Y. Minami, and M. Kudo Radiofrequency ablation of hepatocellular carcinoma: a literature review Int J Hepatol 2011 2011 104685
17. A.R. Kambadakone, and D.V. Sahani Body perfusion CT: technique, clinical applications, and advances Radiol Clin North Am 47 1 2009 161 178
18. K.A. Miles, and M.R. Griffiths Perfusion CT: a worthwhile enhancement? Br J Radiol 76 904 2003 220 231
19. M.R. Meijerink, J.H. van Waesberghe, L. van der Weide, P. van den Tol, S. Meijer, and E.F. Comans et al. Early detection of local RFA site recurrence using total liver volume perfusion CT: initial experience Acad Radiol 16 10 2009 1215 1222
20. D. Ippolito, P.A. Bonaffini, L. Ratti, L. Antolini, R. Corso, and F. Fazio et al. Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor World J Gastroenterol 16 47 2010 5993 6000
21. G. Chen, D.Q. Ma, W. He, B.F. Zhang, and L.Q. Zhao Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma World J Gastroenterol 14 2008 5738 5743
22. Z. Kan, S. Phongkitkarun, S. Kobayashi, Y. Tang, L.M. Ellis, and T.Y. Lee et al. Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model Radiology 237 1 2005 151 158
23. A. Sabir, R. Schor-Bardach, C.J. Wilcox, S. Rahmanuddin, M.B. Atkins, and J.B. Kruskal et al. Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy Am J Roentgenol 191 2008 133 139
24. A.X. Zhu, N.S. Holalkere, A. Muzikansky, K. Horgan, and D.V. Sahani Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma Oncologist 13 2 2008 120 125
25. G. Petralia, P. Summers, S. Viotti, R. Montefrancesco, S. Raimondi, and M. Bellomi Quantification of variability in breath-hold perfusion CT of hepatocellular carcinoma: a step toward clinical use Radiology 265 2012 448 456
26. Z. Rumboldt, R. Al-Okaili, and J.P. Deveikis Perfusion CT for head and neck tumors: pilot study Am Neuroradiol 26 5 2005 1178 1185